Carlsmed (CARL) Preferred Stock Liabilities (2024 - 2025)

Carlsmed's (CARL) quarterly Preferred Stock Liabilities came in at $29.8 million in Q2 2025, down 22.25% YoY from $38.3 million in Q2 2024, and up 119.48% on a QoQ basis from $13.6 million in Q1 2025.

Carlsmed (CARL) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends

Carlsmed (CARL) has 2 years of Preferred Stock Liabilities data on file, last reported at $29.8 million in Q2 2025.

  • Quarterly Preferred Stock Liabilities fell 22.25% year-over-year to $29.8 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $29.8 million (down 22.25% YoY) and the FY2024 annual result came in at $13.6 million, changed N/A from the prior year.
  • Preferred Stock Liabilities advanced to $29.8 million in Q2 2025, from $13.6 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $38.3 million in Q2 2024 to a low of $13.6 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn -
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn -
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn -
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn -
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 Carlsmed 389.87 Mn 276.57 Mn 14.54 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 29.80 Mn
Mar 31, 2025 13.58 Mn
Dec 31, 2024 13.58 Mn
Sep 30, 2024 29.80 Mn
Jun 30, 2024 38.33 Mn